Economic winners and losers after introduction of an effective new therapy depend on the type of payment system

American Journal of Managed Care

Volumn 3, Issue 5, 1997, Pages 743-749

  Weintraub, William S ^a,b,e   Warner, Christi D ^a   Mauldin, Patrick D ^c   Becker, Edmund R ^b   Gomes, Daniel ^d   Cook, John ^d   Kosinski, Andrzej ^b   Boccuzzi, Stephen ^d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

^e EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CAPITATION FEE; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; COST; COST CONTROL; COST OF ILLNESS; ECONOMICS; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; MEDICAL FEE; RECURRENT DISEASE; REIMBURSEMENT; STATISTICS; TRANSLUMINAL CORONARY ANGIOPLASTY; UNITED STATES;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CAPITATION FEE; CORONARY DISEASE; COST CONTROL; COST OF ILLNESS; COSTS AND COST ANALYSIS; FEE-FOR-SERVICE PLANS; HEALTH CARE COSTS; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; MANAGED CARE PROGRAMS; RECURRENCE; UNITED STATES;

EID: 0031132015     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Weintraub WS, Kosinski AS, Brown CL III, King SB III. Can restenosis be predicted after coronary angioplasty from clinical variables? J Am Coll Cardiol 1993;21:6-14.
2. Weintraub WS, Boccuzzi SJ, Klein JL, et al. Lack of effect of lovastatin on restenosis after coronary angioplasty N Engl J Med 1994;331:1331-1337.
3. Topol EJ, Leya F, Pinkerton CA, et al. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. N Engl J Med 1993;329:221-227.
4. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
5. Serruys, PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-495.
6. Weintraub WS, Mauldin PD, Becker ER, Kosinski AS, King SB III. A comparison of the costs of and quality of life after coronary angioplasty and coronary surgery: Results from the Emory Angioplasty vs Surgery Trial (EAST). Circulation 1995;92:2831-2840.
7. Cohen DJ, Krumholz HM, Sukin CA, et al. In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty: Results from a randomized clinical trial. Circulation 1995;92:2480-2487.
8. Ellis SG, Miller DP, Brown KJ, et al. In-hospital cost of percutaneous coronary revascularization: Critical determinants and implications. Circulation 1995;92:741-747.
9. Weintraub WS, Ghazzal ZMB, Douglas JS Jr, et al. Initial management and long term clinical outcome of restenosis after initially successful PTCA. Am J Cardiol 1992;70:47-55.
10. Weintraub WS, Ghazzal ZMB, Douglas JS Jr, et al. Long term clinical follow-up in patients with angiographic restudy after successful angioplasty. Circulation 1993;87:831-840.
11. Weintraub WS, Waksman R, Benard J, et al. The influence of new devices on the costs of interventional procedures. Am J Man Care 1996;2:1199-1208.
12. Mark DB, Talley JD, Topol EJ, et al. Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty. Circulation 1996;94:629-635.